ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 258 filers reported holding ALKERMES PLC in Q3 2016. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $77,000 | -65.0% | 2,574 | -69.2% | 0.00% | -62.5% |
| Q1 2022 | $220,000 | +9.5% | 8,358 | -3.0% | 0.01% | +14.3% |
| Q4 2021 | $201,000 | -70.2% | 8,620 | -68.7% | 0.01% | -68.2% |
| Q2 2021 | $675,000 | +78.6% | 27,513 | +45.3% | 0.02% | +29.4% |
| Q4 2020 | $378,000 | +302.1% | 18,940 | +190.4% | 0.02% | -58.5% |
| Q1 2020 | $94,000 | +40.3% | 6,522 | +120.7% | 0.04% | +127.8% |
| Q2 2019 | $67,000 | +2133.3% | 2,955 | +2562.2% | 0.02% | +1700.0% |
| Q4 2018 | $3,000 | -97.0% | 111 | -93.4% | 0.00% | -99.2% |
| Q1 2017 | $99,000 | -87.3% | 1,690 | -89.8% | 0.13% | -69.8% |
| Q3 2016 | $782,000 | -10.6% | 16,620 | -17.9% | 0.43% | -57.9% |
| Q2 2016 | $875,000 | +641.5% | 20,252 | +1265.6% | 1.02% | +159.6% |
| Q4 2015 | $118,000 | -45.6% | 1,483 | -56.0% | 0.39% | -7.1% |
| Q2 2015 | $217,000 | +76.4% | 3,373 | +67.8% | 0.42% | +286.2% |
| Q1 2015 | $123,000 | – | 2,010 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |